**
A troubling phenomenon is emerging among patients with eczema who are experiencing severe reactions to topical steroid treatments. Known as Topical Steroid Withdrawal (TSW), this condition is increasingly documented online, prompting both concern and calls for further research. As more individuals share their harrowing experiences, medical professionals are grappling with the complexities of TSW, which appears to be underdiagnosed and poorly understood.
The Unseen Battle of Eczema Sufferers
For many individuals, eczema is a lifelong battle. Bethany Gamble, a 21-year-old from Birmingham, has been managing her eczema since childhood with steroid creams, but her situation changed dramatically at the age of 18. “My skin was hot, so inflamed and red. It began to crack and ooze, and the itch was bone deep,” she describes. By 20, she found herself bedridden, reliant on her mother for care, while feeling dismissed by medical professionals. “I was constantly gaslit by doctors,” she recalls. “They kept telling me it was just my eczema and offering me more steroids.”
Bethany’s plight is not unique. Social media platforms, particularly TikTok, have seen a surge in posts tagged #TSW, amassing over a billion views. This collective sharing of experiences highlights a potential epidemic of TSW, a condition that remains widely misunderstood within medical circles.
The Medical Community’s Response
TSW, often referred to as red skin syndrome, is still a topic of significant debate among healthcare providers. While some experts believe it to be a severe reaction to long-term steroid use, others argue that it may merely represent a severe flare-up of eczema itself. The contrast in opinions has left many patients feeling lost and frustrated.
Professor Sara Brown, a consultant dermatologist at the University of Edinburgh, has begun to investigate TSW, driven by her observations of unexplainable symptoms in her patients. “We’re seeing patterns in TSW that cannot be explained by what is known about eczema,” she states. Symptoms such as pronounced skin thickening and extreme shedding have prompted her to seek funding for research into this troubling condition. Alongside Dr Alice Burleigh from the patient advocacy group Scratch That, she is currently conducting a comprehensive study involving hundreds of participants across the UK, analysing various biological samples to uncover the underlying causes of TSW.
Personal Accounts of Suffering and Resilience
Henry Jones, a 22-year-old from High Wycombe, is one of the participants in this groundbreaking research. His journey began with occasional steroid use, which escalated into a debilitating cycle of symptoms. “Something didn’t feel right,” he recalls, as he struggled with the intense physical and emotional toll of TSW. The once-active student found himself isolated, unable to attend classes or socialise, battling thoughts of despair. “My world became a dark hole caused by the weight of my skin.”
Similarly, Karishma Leckraz, 32, from Kent, initially dismissed her symptoms, believing her experience to be different due to her skin colour. Her journey through denial and pain has been profound. “TSW took everything away from me. I had to hide from the world for so long,” she admits. Now, she focuses on raising awareness, using her platform to connect with others facing similar challenges.
The Search for Effective Treatments
The impact of TSW extends beyond physical health; it significantly affects mental well-being. Many patients report heightened anxiety and social isolation due to their conditions. The National Eczema Society’s Andrew Procter acknowledges the dilemma facing patients: “We know that steroids work for the many millions who use them. But we also have a condition that at the moment can’t be explained, which is causing real fear – and that is completely understandable.”
While steroid creams continue to be the go-to treatment for eczema, patients experiencing TSW-like symptoms often find themselves in a frustrating cycle of referrals and long waiting times for specialist care. At the Royal London Hospital, consultant dermatologist Dr Alia Ahmed offers a multidisciplinary approach to treatment, incorporating psychological support alongside medical interventions. “The psychological impact, as well as the physical effects, is huge,” she notes, emphasising the need for tailored care that addresses both aspects of the patient’s experience.
The Medicines and Health Regulatory Authority (MHRA) recognised TSW as a severe reaction to steroid creams in 2021, yet it remains classified as relatively rare. As a result, many patients are left navigating their treatment options alone, often resorting to private clinics for alternative therapies such as Cold Atmospheric Plasma (CAP) therapy, which is not yet endorsed by the NHS.
Why it Matters
The increasing visibility of TSW and the shared experiences of those affected underline a critical gap in our understanding of eczema treatments and their consequences. As more individuals speak out, the urgent need for research and education within the medical community becomes clear. TSW is not merely a side effect; it represents a significant public health issue that demands attention. By fostering awareness and encouraging open dialogue, we can begin to address the complexities of this condition and improve the quality of care for countless individuals living with eczema.
